Cargando…
Tolerogenic insulin peptide therapy precipitates type 1 diabetes
Daniel et al. (https://doi.org/10.1084/jem.20110574) have previously published in JEM a study on the preventive effect of tolerogenic vaccination with a strong agonist insulin mimetope in type 1 diabetes. Our study now challenges these results and shows that osmotic pump delivery of the modified ins...
Autores principales: | Bergman, Marie-Louise, Lopes-Carvalho, Thiago, Martins, Ana-Catarina, Grieco, Fabio A., Eizirik, Décio L., Demengeot, Jocelyne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502418/ https://www.ncbi.nlm.nih.gov/pubmed/28536239 http://dx.doi.org/10.1084/jem.20160471 |
Ejemplares similares
-
Reply to “Tolerogenic insulin peptide therapy precipitates type 1 diabetes”
por: Daniel, Carolin, et al.
Publicado: (2017) -
On the Immense Variety and Complexity of Circumstances Conditioning Pancreatic β-Cell Apoptosis in Type 1 Diabetes
por: Eizirik, Decio L., et al.
Publicado: (2012) -
Tolerogenic citrullinated peptide for arthritis
por: Gertel, Smadar, et al.
Publicado: (2015) -
Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by Lipopolysaccharide
por: Caramalho, Iris, et al.
Publicado: (2003) -
Arrested B Lymphopoiesis and Persistence of Activated B Cells in Adult Interleukin 7(−/)− Mice
por: Carvalho, Thiago L., et al.
Publicado: (2001)